BACK
IMAC Holdings, Inc.
$0.0400
0.00%
No data for this timeframe.
Vol
Inst. Holders1 funds
Inst. Value$1.7K
Inst. Activity1 buys / 0 sells
Reddit Sentiment47° Neutral
Exchange OTC·Sector Services-Specialty Outpatient Facilities, NEC·Inc. DE·CIK 0001729944·Prev Close $0.0400
Recent Activity
Inst.
BANK OF AMERICA CORP — ADD
12 shares ($13.00)
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| JONES FINANCIAL COMPANIES LLLP | $1.7K | — |
Reddit Sentiment
47°▲
Neutral
Bearish
Neutral
Bullish
1 institutional holders with $1.7K total value (40 shares) as of 2025-Q1. Top holders: JONES.
Top Institutional Holders — 2025-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | JONES FINANCIAL COMPANIES LLLP | 40 | $1.7K | 100.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | ADD | 8 | 12 | +50.0% | $13.00 | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2024-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2024-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Mar 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Dec 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
47°
Neutral
Bearish
Neutral
Bullish
32 mentions
5 bullish
7 bearish
30 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 9, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Jun 9, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Jun 6, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Jun 5, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Jun 4, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Jun 4, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Jun 3, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Jun 3, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Jun 1, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 31, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 29, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 29, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 22, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 22, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 21, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 21, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 14, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 14, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 8, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 7, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 7, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 30, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Apr 30, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Apr 24, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 24, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 21, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 21, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 12, 2026 | 2 | 50° Neutral | 0 | 0 | 2 |
| Apr 12, 2026 | 2 | 50° Neutral | 0 | 0 | 2 |
| Mar 13, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.